Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
Fourth Quarter & Full Year 2025 Results
Fourth quarter and full year 2025 results will be reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation will be followed by a Q&A session.
Press Releases
Upcoming Events
12Jan
29Jan
Fourth Quarter & Full Year 2025 Results
Fourth quarter and full year 2025 results will be reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation will be followed by a Q&A session.
14:30 - 16:00 CET (8:30am – 10am EDT)
Quarterly results
23Apr
First Quarter 2026
First quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation will be followed by a Q&A session.
Quarterly results
30th Consecutive Year of Dividend Increase
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00